A Combination of TLR-4 Agonist and Saponin Adjuvants Increases Antibody Diversity and Protective Efficacy of a Recombinant West Nile Virus Antigen

npj Vaccines - United Kingdom
doi 10.1038/s41541-018-0077-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants

PLoS ONE
Multidisciplinary
2012English

A Vaccine Formulated With a Combination of TLR-2 and TLR-9 Adjuvants and the Recombinant Major Outer Membrane Protein Elicits a Robust Immune Response and Significant Protection Against a Chlamydia Muridarum Challenge

Microbes and Infection
Infectious DiseasesImmunologyMicrobiology
2014English

Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile Virus Infection

Current Tropical Medicine Reports
Infectious DiseasesAllergyImmunology
2015English

Toll-Like Receptor 3 Has a Protective Role Against West Nile Virus Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2008English

Complement Modulates Pathogenesis and Antibody-Dependent Neutralization of West Nile Virus Infection Through a C5-Independent Mechanism

Virology
Virology
2009English

West Nile Virus

JAMA - Journal of the American Medical Association
Medicine
2012English

West Nile Virus Antibody Prevalence in Wild Mammals, Southern Wisconsin

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2006English

West Nile Virus

CMAJ
Medicine
2005English

West Nile Virus Infection

CMAJ
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy